Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $565.73 | 37 | 97.2% |
| Consulting Fee | $16.18 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $161.46 | 11 | $0 (2020) |
| UCB, Inc. | $101.46 | 7 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $84.12 | 3 | $0 (2020) |
| Janssen Biotech, Inc. | $68.28 | 5 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $62.81 | 4 | $0 (2018) |
| Daiichi Sankyo Inc. | $50.44 | 4 | $0 (2018) |
| AbbVie, Inc. | $14.59 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $14.19 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $12.85 | 1 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $11.71 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $73.91 | 5 | UCB, Inc. ($31.81) |
| 2019 | $133.25 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($59.12) |
| 2018 | $256.33 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($89.20) |
| 2017 | $118.42 | 6 | Intercept Pharmaceuticals, Inc. ($52.29) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/03/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Immunology | ||||||
| 01/30/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 01/21/2020 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Immunology | ||||||
| 01/15/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/06/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 11/14/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Consulting Fee | In-kind items and services | $16.18 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 08/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Immunology | ||||||
| 06/17/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2019 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 04/05/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 01/31/2019 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 01/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/09/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Immunology | ||||||
| 11/20/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Gastroenterology | ||||||
| 11/19/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Immunology | ||||||
| 11/08/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Anemia | ||||||
| 11/06/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Gastroenterology | ||||||
| 08/20/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Immunology | ||||||
| 08/12/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Immunology | ||||||
| 07/25/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 1,028 | 1,788 | $549,417 | $109,242 |
| 2020 | 4 | 680 | 1,168 | $360,665 | $71,891 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 599 | 1,316 | $366,126 | $71,748 | 19.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 249 | 277 | $120,218 | $23,271 | 19.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 119 | 127 | $35,941 | $8,099 | 22.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 61 | 68 | $27,132 | $6,124 | 22.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 435 | 879 | $244,362 | $48,709 | 19.9% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 169 | 204 | $88,536 | $17,279 | 19.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2020 | 50 | 53 | $14,999 | $3,219 | 21.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2020 | 26 | 32 | $12,768 | $2,684 | 21.0% |
About Dr. Donna Lager, M.D
Dr. Donna Lager, M.D is a Anatomic Pathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942270178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Lager, M.D has received a total of $581.91 in payments from pharmaceutical and medical device companies, with $73.91 received in 2020. These payments were reported across 38 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($565.73).
As a Medicare-enrolled provider, Lager has provided services to 1,708 Medicare beneficiaries, totaling 2,956 services with total Medicare billing of $181,133. Data is available for 2 years (2020–2021), covering 8 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology
- Location Dallas, TX
- Active Since 01/23/2006
- Last Updated 09/21/2015
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1942270178
Products in Payments
- Cimzia (Drug) $101.46
- XIFAXAN (Drug) $87.09
- STELARA (Biological) $68.28
- Trulance (Drug) $62.81
- OCA (Drug) $52.29
- INJECTAFER (Drug) $50.44
- OCALIVA (Drug) $31.83
- XIFAXANIBSD (Drug) $31.80
- UCERIS TABLETS (Drug) $30.47
- RELISTOR ORAL (Drug) $26.29
- Humira (Biological) $14.59
- PREPOPIK (Drug) $12.85
- NASCOBAL (Drug) $11.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Dallas
Dr. Olga Weinberg, M.d, M.D
Anatomic Pathology — Payments: $54,995
Dr. Kirthi Kumar, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $7,027
Richard Hopley, Md, MD
Anatomic Pathology — Payments: $5,797
Xin Zhou, Md, MD
Anatomic Pathology — Payments: $2,611
Elizabeth Dole, M.d, M.D
Anatomic Pathology — Payments: $779.72
Rujuta Kanhere, M.d, M.D
Anatomic Pathology — Payments: $290.41